Westminster Health Forum

The future for NICE in health and social care

TO BE PUBLISHED February 2020


This conference will be a timely opportunity to discuss the next steps for NICE - looking at:


  • Developing evidence-based guidelines;
  • The impact of NICE’s recommendations on decision-making; and
  • The role of NICE in accelerating the uptake of innovation.

The conference takes place in light of the publication of the Life Sciences Sector Deal 2, which committed to making additional funding available to NICE and increasing the number of evaluations of digital products by 2020.


It also follows the introduction of the Voluntary Scheme for Branded Medicines Pricing and Access, which included plans to provide faster assessments of the clinical and cost-effectiveness of new medicines.


Speakers


There will be keynote addresses from: Meindert Boysen, Director, Centre for Health Technology Evaluation, NICE and Professor Gillian Leng, Deputy Chief Executive and Director of Health and Social Care, NICE.


Further confirmed speakers include: Professor Andrew Briggs, London School of Hygiene & Tropical Medicine; Caroline Cake, Health Data Research UK; Professor Matthew Cripps, NHS England and NHS Improvement; Emily Crossley, Duchenne UK; Hilary Hutton-Squire, Gilead; Dr Alan MacDonald, Scottish Medicines Consortium and NHS Grampian; Professor Shanaya Rathod, Wessex Clinical Research Network and Wessex Academic Health Sciences Network and Doris-Ann Williams, BIVDA


The agenda


  • Priorities for NICE and the policy landscape for health and social care;
  • Measuring the impact of NICE guidelines, utilising data, and improving patient and public engagement;
  • Challenges for accelerating the uptake of innovative medicines and medical technologies:
    • Future funding arrangements as NICE expands;
    • Shared decision-making, patient choice, and NHS collaboration with NICE;
    • Developing future guidelines and increasing adoption;
    • Priorities for the pharmaceutical industry - access, value, and improving outcomes; and
    • Evaluating health technologies - the role of HealthTech Connect.
  • Next steps for policy.


Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF


Shortly after every Westminster Health Forum seminar, a briefing document is produced. This is distributed to all delegates on the day as well as to our policymaker contacts in government, and to stakeholders more widely.

A seminar publication provides a timely record of proceedings, and acts as a guide to the latest thinking on current policy issues for those unable to be at the event.

This publication includes

Presentations

Contributions from keynotes and panellists, including accompanying slides*
*Subject to approval


Delegate Pack

Information from the day, including delegate list, biographies and agenda

Q&A

Transcript of questions and comments posed to speakers from attending delegates


Articles

Supplementary articles from speakers
and delegates